bluuebunny/crossref_metadata_2025_split huggingface dataset:
A Translingual Voice in Japanese Literature: A Conversation between Li Kotomi and Elaine Wong
Authors: Wong Elaine , Kotomi Li 
Published: April 2024

Abstract
Li Kotomi learned Japanese as a teenager in Taiwan. She is a prolific author writing in Japanese and has received several literary awards in Japan, including an Akutagawa Prize in 2021. Li translates her own works into Mandarin Chinese, her first language. Her novels and short stories often depict experiences of crossing between Japanese and Chinese, such as how a character’s encounter with a new language shapes or even determines her understanding of a new country. In this interview, Li talks about the influences of language and linguistic differences on her creative writing, her learning of Japanese, her thoughts about Japanese and Chinese, self-translation, and linguistic identity. She also discusses, from a queer perspective, her way of innovating Japanese literature by incorporating original Chinese classical poems into contemporary Japanese fiction, and how this act of innovation subverts heteronormativity in Chinese and Japanese literatures for different reasons.
Roundtable Discussion: Translation in Creativity
Authors: Kelbert Eugenia , Goldsworthy Vesna , Reynolds Matthew , Robinson Douglas 
Published: April 2024

This Forum, appearing in each issue of the Journal of Literary Multilingualism, aims to continue the conversation started in the very first issue, where we collected articles which assessed and debated the field of literary multilingualism studies. The Forum is a space for shorter, more informal reflections on the field and its future: position papers, dialogues between scholars, roundtable discussions, responses to articles within the journal, and responses to recent multilingualism conferences or events. We welcome proposals for contributions, particularly from marginalized perspectives or on neglected aspects of literary multilingualism. Please contact us directly to discuss ideas.
For this Forum, we present a roundtable discussion, organized and moderated by Eugenia Kelbert, in which Vesna Goldsworthy, Matthew Reynolds, and Douglas Robinson share some of their ideas around the relationship between translation and multilingual writing, particularly in relation to their intersecting roles as writers, translators, and academics.
— Juliette Taylor-Batty and Till Dembeck, Forum Moderators
The study of literary multilingualism exists within the context of recent attempts, by several scholars in comparative literature, to make sense of multilingual and/or global literary practices. From the translation zone (Apter) to born-translated (Walkowitz) or untranslatable fiction, these attempts have almost invariably involved translation, as a concept if not as a practice. What is, then, the place of translation when it comes to understanding multilingual and translingual writing? How does this theoretical debate relate to the actual practice of literary translation? And what happens to literary style when theorists of translation and translators experiment with multilingual writing or when translingual writers translate? The present discussion explores the hitherto undefined zone of creative interaction between translation and multilingual writing in the hope of contributing to the more conceptual debates from a hands-on perspective. It is based on the roundtable entitled “Stylistic Border Crossings in Multilingual and Translated (Con)texts” that was part of the Stylistic Border Crossings In and Beyond Translation conference held on March 9–10, 2023.1 The conference and the roundtable were organized by Eugenia Kelbert with the British Centre for Literary Translation and the East Centre, University of East Anglia.
Each of the three guests wears a combination of multiple hats that bridge theory and practice and include “translingual writer,” “literary translator,” “translation studies scholar,” “writer,” and “literary scholar.”
— Eugenia Kelbert
Big Reason: Public Discussion of Big Questions
Authors: Gauch Hugh G. 
Published: April 2024

Abstract
By ‘big reason’ is meant reason that can (1) tackle life’s big questions, like whether God exists, and (2) address a big audience of virtually everyone by means of reasons that count across worldviews. The antithesis of big reason is small reason, the contention that any reasons and evidence in favor of a given worldview count only within the small audience of that worldview. Big reason promotes finding the truth, including the truth of Christianity, and thereby it promotes human flourishing. This article defends big reason by presenting a model of public reason and then applying this model to the evidence for Christianity from fulfilled Bible prophecies.
Hospital Quality Mediates Impact of Care Fragmentation Following Elective Colectomy
Authors: Sakowitz Sara , Bakhtiyar Syed Shahyan , Mallick Saad , Cho Nam Yong , Kim Shineui , Le Nguyen K. , Lee Hanjoo , Benharash Peyman 
Published: April 2024

Background Readmission at a non-index hospital, or care fragmentation (CF), has been previously linked to greater morbidity and resource utilization. However, a contemporary evaluation of the impact of CF on readmission outcomes following elective colectomy is lacking. We additionally sought to evaluate the role of hospital quality in mediating the effect of CF. Methods All records for adults undergoing elective colectomy were tabulated from the 2016 to 2020 Nationwide Readmissions Database. Patients readmitted non-electively within 30 days to a non-index center comprised the CF cohort (others: Non-CF). Hierarchical mixed-effects models were constructed to ascertain risk-adjusted rates of major adverse events (MAEs, a composite of in-hospital mortality and any complication) attributable to center-level effects. Hospitals with risk-adjusted MAE rates ≥50th percentile were considered Low-Quality Hospitals (LQHs) (others: High-Quality Hospitals [HQHs]). Results Of 68,185 patients readmitted non-electively within 30 days, 8968 (13.2%) were categorized as CF. On average, CF was older, of greater comorbidity burden, and more often underwent colectomy for cancer, relative to Non-CF. Following risk adjustment, CF remained independently associated with greater likelihood of MAE (adjusted odds ratio [AOR] 1.16, 95% Confidence Interval [CI] 1.05-1.27) and per-patient expenditures (β+$2,280, CI +$1080-3490). Further, readmission to non-index LQH was linked with significantly increased odds of MAE, following initial care at HQH (AOR 1.43, CI 1.03-1.99) and LQH (AOR 1.72, CI 1.30-2.28; Reference: Non-CF). Conclusions Care fragmentation was associated with greater morbidity and resource utilization at readmission following elective colectomy. Further, rehospitalization at non-index LQH conferred significantly inferior outcomes. Novel efforts are needed to improve continuity of care.
Reconsidering Fresh Frozen Plasma Availability to Reduce Blood Product Waste During Massive Transfusion Events in Trauma
Authors: Shen Aricia , Di Meo Brent , Perez Ingrid A. , Hashim Yassar , Ko Ara , Margulies Daniel R. , Klapper Ellen B. , Barmparas Galinos 
Published: April 2024

Background Within component therapy of massive transfusion protocol (MTP) in trauma, thawed plasma is particularly susceptible to expiring without use given its short 5-day shelf life. Optimizing the number of thawed products without compromising safety is important for hospital resource management. The goal is to examine thawed plasma utilization rates in trauma MTP events and optimize the MTP cooler content at our Level I trauma center. Methods Trauma MTP activations from 01/2019 to 12/2022 were retrospectively reviewed. During the study period, blood products were distributed in a 12:12:1 ratio of packed red blood cells (pRBC): plasma: platelets per cooler, with up to 4 additional units of low-titer, group O whole blood (LTOWB) available. The primary measure was percent return of unused, thawed plasma. Results There were 367 trauma MTP activations with a median (IQR) activation call-to-first cooler delivery time of 8 (6-10) minutes. 73.0% of thawed plasma was returned to the blood bank unused. In one third of MTP activations, all dispensed plasma was returned. The majority (74.1%) of patients required 6 or fewer units of plasma. In 81.5% of activations, 10 or fewer units of plasma and 10 or fewer units of pRBC were used. Discussion The majority of trauma MTP requirements may be accommodated with a reduced cooler content of 6 units pRBC, 6 units plasma, and 1 pheresis platelets, buffered by up to 4 units LTOWB (approximates 4 units of pRBC/4 units plasma), in conjunction with a sub-10min cooler delivery time. Follow-up longitudinal studies are needed.
Unravelling pituitary tumours in medically treated patients with acromegaly: the impact of systematic MRI reassessment
Authors: Atai Shahriar , Knudtzon Andersen Martin , Wiedmann Markus , Dahlberg Daniel , Øystese Kristin Astrid B , Bollerslev Jens , Ringstad Geir , Heck Ansgar 
Published: April 2024

Background In acromegaly, the primary tumor is usually found during magnetic resonance imaging (MRI) of the pituitary gland. A remnant tumor after surgery is, however, harder to depict. When a tumor is missed, the remaining option is usually lifelong pharmacological treatment. Purpose To identify tumors by reassessment of all available MRI scans in pharmacologically treated patients, operated or not, and to compare our results with the routine MRI reports. Material and Methods Adult patients diagnosed with acromegaly and managed at a tertiary care center between 2005 and 2021 and currently on pharmacological treatment were included. MRI scans were evaluated in a standardized manner and classified independently by a radiologist and an endocrinologist into “certain,” “suspected,” or “no tumor.” In case of disagreement, consensus was achieved with a senior neuroradiologist. The results were compared using the clinical radiologists’ routine MRI reports. Results We identified certain and suspected tumors in 29/74 and 36/74 patients, respectively. No tumor was identified in nine patients. In five of these, no MRI contrast agent was given. Discrepancy between our results and the routine MRI reports was found in 31/74 patients ( P = 0.01). In 22 patients, the routine reports described no tumor while we identified certain tumors in 2/22 patients and suspected tumors in 13/22 patients. Conclusion In most patients with pharmacologically treated acromegaly, we identified a certain or suspected pituitary tumor. These findings were more frequent compared to the routine MRI reports. Based on our results, patients will be considered for a change in long-term treatment modality.
Overview of Trends in Anemia and Iron Deficiency in the Mexican Population From 1999 to 2018-19
Authors: De la Cruz-Góngora Vanessa , Villalpando Salvador , Shamah-Levy Teresa 
Published: April 2024

Background: Despite the emergence of diverse programs in Mexico to address anemia and micronutrient deficiencies in disadvantaged groups, progress on reducing their prevalence has stagnated. In Mexico, anemia surveillance at the population level is conducted through the National Health and Nutrition Survey ENSANUT (for its acronym in Spanish). Objective: To overview the trends in anemia and iron deficiency (ID) from 1999 to 2018-19 in the Mexican population before COVID-19 pandemic. Methods: Data from five nationwide surveys in Mexico were used. Where available, data on anemia, ID, and ID anemia (IDA) were extracted from ENSANUTs 1999, 2006, 2012, 2016, and 2018-19 in participants from 1 to 99 years old. Blood sample collection methods were similar across surveys (1999-2018) where capillary drop blood was used to estimate Hb using a HemoCue and serum blood samples to measure ferritin and C-reactive protein concentration. Results: The trend in anemia prevalence shows a U-shape from 1999 to 2018-19 in <60 years old. In older adults (≥60 years), an increasing trend was observed. Anemia declined progressively from 1999 to 2012 but increased from 2016 to 2018-19 in comparison with 2012. In contrast, ID declined from 2006 to 2018-19, mainly in children, while IDA did not change over this period. In older adults, ID prevalence remained constant over time. Conclusions: The shifting trend in anemia prevalence across ENSANUTs 1999 through 2018-19 did not mimic the decreasing trend of ID over the same period of time. Other noncausal factors seem to play an important role in the variability of hemoglobin measurements.
Seroprevalence of sexually transmitted infections over 44 years – A cross-sectional study in Sweden
Authors: Andersson Nirina , Waterboer Tim , Nylander Elisabet , Idahl Annika 
Published: April 2024

Background Sexually transmitted infections (STIs) may cause substantial individual suffering and a large economic burden for society. This study examined the seroprevalence of Chlamydia trachomatis, Mycoplasma genitalium, herpes simplex virus (HSV) types 1 and 2, and several human papillomaviruses (HPV) in the Swedish population over time. Methods The study population consisted of 30-year-old women attending maternity care, and 50 year-old men and women attending health check-ups, from 1975 to 2018. Antibody status was determined by multiplex serology and quantified using median reporter fluorescence intensity (MFI). Results A total of 891 samples were analysed (519 from 30-year-old women, 186 from 50 year-old women and 186 from 50 year-old men). Of these, 41.5% showed seropositivity for Chlamydia trachomatis, 16.7% for Mycoplasma genitalium, 70.5% for HSV-1, 14.9% for HSV-2, 13.2% for high-risk HPV, and 8.3% for low-risk HPV. Seropositivity for Mycoplasma genitalium, HSV-1 and especially Chlamydia trachomatis decreased over time. Conclusions There was a decrease over time in Chlamydia trachomatis seroprevalence, probably due to contact tracing, testing and early treatment; this might also have affected Mycoplasma genitalium seroprevalence. Despite the reduction, seroprevalences are still high, so continued and new efforts to reduce STI incidence are essential.
Tumours of the foot: A 10 years retrospective analysis
Authors: Ajit Singh Vivek , Sandhu Vinesh , Tze Yong Choo , Yasin Nor Faissal 
Published: April 2024

Introduction The foot is a complex structure composed of several tissues, each of which can be the origin of the proliferation and development of the tumour. Most lesions about the foot are reactive or inflammatory, but some are true neoplasms. Method This is a retrospective analysis of 4997 patient records treated in the Orthopaedic Oncology Unit of University Malaya Medical Centre, Malaysia, between 1 January 2010 to 31 December 2020. Demographic data of 195 patients with foot tumours were analysed out of 4997 neoplasm patients. Results There were 195 cases of foot tumours: 148 were benign, and 47 were malignant. 47 were bone tumours, 4 were metastases, and 144 were soft tissue tumours. Six patients succumbed to the disease, two cases of giant cell tumour (GCT) and one patient with synovial sarcoma had a recurrence. Treatment of foot tumours was wide resection in general. However, in metastasis cases, amputation was done. The majority of tumours were in the toes and dorsum of the foot. Soft tissue tumours of the foot occur in the elderly population in contrast to bone tumours, mainly in the second decade of life. The gender distribution was almost equal for foot tumours. Ganglion and Giant Cell Tumour of the bone are the commonest benign soft tissue and bone tumours. The most common malignant soft tissue and bone tumours are malignant melanoma and chondrosarcoma. The amputation rate is 5.64% the recurrence rate is 1.54%. Mortality rate is 3.08%. The MSTS score is 79%, and the TESS score is 76.23%. Conclusion Foot tumours are relatively rare, mostly originating from soft tissue and exhibiting a benign nature. Nonetheless, a noteworthy proportion—approximately a quarter of these tumours—demonstrate malignancy. The surgical interventions undertaken in managing these tumours and associated functional outcomes generally yield acceptable results.
Analysis of the Complexity of Palliative Care for Cancer Patients
Authors: Mocha Campillo Fátima , Comín Orce Ana María , Monreal Cepero María Luna , Trincado Cobos Pablo , Gómez Mugarza Pablo , Barriendos Sanz Susana , Pascual de la Fuente Natalia , Ruffini Egea Sofia , Martínez Trufero Javier 
Published: April 2024

Introduction The Spanish National Health System has defined complexity as a set of factors of increased difficulty that require the intervention of a palliative care team. Palliative care aims to improve the quality of life of patients with chronic terminal illnesses. This study aims to describe the degree of complexity of cancer patients in palliative care, to determine which elements of complexity are most prevalent and to determine which other hospital clinical factors are associated with the level of complexity. Methods This study is a descriptive, observational, and cross-sectional analysis that included patients diagnosed with advanced oncological pathology undergoing palliative treatment who were admitted to the Medical Oncology ward of the Miguel Servet University Hospital between March and April 2023. Result A total of 100 patients were selected for the study. According to the IDC-Pal, 68% of patients were classified as highly complex, 26% of patients were complex and only 6% of patients were classified as non-complex. The presence of pain ( P < .001), nausea and vomiting ( P = .027), depression ( P = .033) and functional status ( P = .011) were statistically independent predictors of high complexity. Discussion This study has shown that a high proportion of hospitalized palliative care cancer patients have high complexity, suggesting a good matching of healthcare resources to patient complexity. Four factors related to complexity have been identified, namely pain, nausea and vomiting, depression and a bedridden functional state. The presence of any of the 4 factors could help healthcare professionals to identify patients for early specialized palliative care.
Transdermal Opioids and the Quality of Life of the Cancer Patient: A Systematic Literature Review
Authors: Reis Patricia Santos , Kraychete Durval Campos , Pedreira Emilie de Magalhães , Barreto Eduardo Silva Reis , Antunes Júnior César Romero , Alencar Vinicius Borges , Souza Anna Karla do Nascimento , Lins-Kusterer Liliane Elze Falcão , Azi Liana Maria Torres de Araujo 
Published: April 2024

Objective: This systematic literature review aims to evaluate the effectiveness of transdermal opioids in managing cancer pain and their impact on the quality of life (QoL) of patients. Data sources: A systematic literature review conducted following the PRISMA protocol, focusing on randomized clinical trials found in the Lilacs, Embase, PubMed, and SciELO databases over the last 20 years. Study selection and data extraction: We included randomized clinical trials, published in English, Portuguese, or Spanish, which assessed the impact of transdermal opioids on the QoL. Data extraction was facilitated using the Rayyan app. Data synthesis: Six articles meeting the inclusion and exclusion criteria were analyzed. These studies covered a population ranging from 24 to 422 cancer patients experiencing moderate to severe pain. The risk of bias was assessed in each study, generally being categorized as uncertain or high. Relevance to patient care and clinical practice: The findings indicate that the analgesic effectiveness and side effects of transdermal formulations (specifically buprenorphine and fentanyl) for managing moderate to severe cancer pain are comparable to, or in some cases superior to, those of oral opioids traditionally employed. Conclusions: Transdermal therapy was suggested to have several advantages over oral opioid therapy in enhancing cancer patients’ QoL. These benefits span various dimensions, including pain management, physical functioning, mental health, vitality, overall patient improvement, anger/aversion, strength/activity, general QoL, cognitive and emotional functions, fatigue, and insomnia.
Ruminant model for hemodialysis cannulation
Authors: Lovelady April , Glowczwski Alan , Glowczwski Justin , Azimuddin Ahad , Ross John , Hohmann Stephen , Fridley Jennifer , Simon Bradley T 
Published: April 2024

Background: Preventative strategies that minimize hemodialysis access complications remain limited. Objective: This study aimed to address this gap by developing a Caprine cannulation model to investigate the impact of repeated cannulations on vascular access patency rates. Research design and measures: In this pilot study, a meta-analysis was conducted using experimental control data from four trials to explore the impact of Caprine breed (independent variable) on the dependent variables that affect hemodialysis cannulation, including AVF growth, AVF depth, and flow rate. Subjects: Arteriovenous Fistulas (AVFs) were created using the carotid artery and jugular vein in the necks of seven goats from the French alpine, dwarf, and pygmy breeds. All seven AVFs exhibited vessel remodeling patterns similar to that observed in humans and remained patent, enabling hemodialysis access over the 6 month study. Results: Over the course of 18 weeks, a total of 291 cannulations were completed using standard 15 g dialysis needles without complications demonstrating the feasibility of using the Caprine species as a cannulation model. The ease of access coupled with the animals’ cooperative behavior further contributes to the suitability of the Caprine species for hemodialysis investigations. Notably, no infections or clinically significant incidents were observed throughout the study. Conclusions: The stability of AVF patency and flow underscores the viability and potential of the Caprine species animal model as a valuable research platform for exploring interventions aimed at improving vascular access survival in hemodialysis patients.